These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 20676141

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. c-Myc overexpression sensitizes Bim-mediated Bax activation for apoptosis induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through regulating Bcl-2/Bcl-xL expression.
    Jiang X, Tsang YH, Yu Q.
    Int J Biochem Cell Biol; 2007; 39(5):1016-25. PubMed ID: 17331788
    [Abstract] [Full Text] [Related]

  • 3. Vorinostat-induced apoptosis in mantle cell lymphoma is mediated by acetylation of proapoptotic BH3-only gene promoters.
    Xargay-Torrent S, López-Guerra M, Saborit-Villarroya I, Rosich L, Campo E, Roué G, Colomer D.
    Clin Cancer Res; 2011 Jun 15; 17(12):3956-68. PubMed ID: 21652541
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis.
    Chen S, Zhang Y, Zhou L, Leng Y, Lin H, Kmieciak M, Pei XY, Jones R, Orlowski RZ, Dai Y, Grant S.
    Blood; 2014 Oct 23; 124(17):2687-97. PubMed ID: 25208888
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. RhoB upregulation leads to either apoptosis or cytostasis through differential target selection.
    Marlow LA, Bok I, Smallridge RC, Copland JA.
    Endocr Relat Cancer; 2015 Oct 23; 22(5):777-92. PubMed ID: 26206775
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition.
    Nakagawa T, Takeuchi S, Yamada T, Ebi H, Sano T, Nanjo S, Ishikawa D, Sato M, Hasegawa Y, Sekido Y, Yano S.
    Cancer Res; 2013 Apr 15; 73(8):2428-34. PubMed ID: 23382048
    [Abstract] [Full Text] [Related]

  • 10. The sensitivity of diffuse large B-cell lymphoma cell lines to histone deacetylase inhibitor-induced apoptosis is modulated by BCL-2 family protein activity.
    Thompson RC, Vardinogiannis I, Gilmore TD.
    PLoS One; 2013 Apr 15; 8(5):e62822. PubMed ID: 23667527
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim.
    Zhao Y, Tan J, Zhuang L, Jiang X, Liu ET, Yu Q.
    Proc Natl Acad Sci U S A; 2005 Nov 01; 102(44):16090-5. PubMed ID: 16243973
    [Abstract] [Full Text] [Related]

  • 14. Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complex.
    Piazza R, Magistroni V, Mogavero A, Andreoni F, Ambrogio C, Chiarle R, Mologni L, Bachmann PS, Lock RB, Collini P, Pelosi G, Gambacorti-Passerini C.
    Neoplasia; 2013 May 01; 15(5):511-22. PubMed ID: 23633923
    [Abstract] [Full Text] [Related]

  • 15. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.
    Chen MC, Huang HH, Lai CY, Lin YJ, Liou JP, Lai MJ, Li YH, Teng CM, Yang CR.
    Oncotarget; 2016 Jan 05; 7(1):402-17. PubMed ID: 26587975
    [Abstract] [Full Text] [Related]

  • 16. PI3K/mTOR inhibition markedly potentiates HDAC inhibitor activity in NHL cells through BIM- and MCL-1-dependent mechanisms in vitro and in vivo.
    Rahmani M, Aust MM, Benson EC, Wallace L, Friedberg J, Grant S.
    Clin Cancer Res; 2014 Sep 15; 20(18):4849-60. PubMed ID: 25070836
    [Abstract] [Full Text] [Related]

  • 17. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300.
    Jeung YJ, Kim HG, Ahn J, Lee HJ, Lee SB, Won M, Jung CR, Im JY, Kim BK, Park SK, Son MJ, Chung KS.
    Biochim Biophys Acta; 2016 Nov 15; 1863(11):2584-2593. PubMed ID: 27452907
    [Abstract] [Full Text] [Related]

  • 18. Histone deacetylase inhibitor potentiates chemotherapy-induced apoptosis through Bim upregulation in Burkitt's lymphoma cells.
    Dos Santos Ferreira AC, Fernandes RA, Kwee JK, Klumb CE.
    J Cancer Res Clin Oncol; 2012 Feb 15; 138(2):317-25. PubMed ID: 22131152
    [Abstract] [Full Text] [Related]

  • 19. The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells.
    Chen S, Zhao Y, Gou WF, Zhao S, Takano Y, Zheng HC.
    PLoS One; 2013 Feb 15; 8(11):e79781. PubMed ID: 24236158
    [Abstract] [Full Text] [Related]

  • 20. Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.
    Shankar S, Davis R, Singh KP, Kurzrock R, Ross DD, Srivastava RK.
    Mol Cancer Ther; 2009 Jun 15; 8(6):1596-605. PubMed ID: 19509267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.